Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
500 participants
OBSERVATIONAL
2022-03-16
2027-03-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Biocollection of Patients With ANCA Associated Vasculitis
NCT05364892
(68)Ga-FAPI PET/CT in Patients With ANCA-associated Vasculitis
NCT07151521
Defining Immune Tolerance in ANCA-associated Vasculitis (AAV)
NCT01934504
Observation Study of Clinical Manifestation and Outcome in Chinese Patients With Pulmonary Vasculitis
NCT02126098
Alemtuzumab for ANCA Associated Refractory Vasculitis
NCT01405807
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The baseline visit includes the following items: detailed demographics, medical and family history, medication history, health behaviors, physical activity, and anthropometric measures. The laboratory parameters of chemistry test. After the baseline visit, participants will return annually for follow-up visits and evaluation. The evaluating items of follow-up visits are similar to the baseline visit, and sample collection.
The principal clinical outcomes of the study can be broadly categorized as end stage renal disease and death. Death is further clarified as cardiac, infectious, renal, others, or unknown.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Xiangya Hospital
No Intervention
No Intervention
The Second Xiangya Hospital
No Intervention
No Intervention
The Third Xiangya Hospital
No Intervention
No Intervention
Hunan Provincial People's Hospital
No Intervention
No Intervention
Xiangtan Central Hospital
No Intervention
No Intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No Intervention
No Intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Central South University
OTHER
The Third Xiangya Hospital of Central South University
OTHER
Hunan Provincial People's Hospital
OTHER
Xiangtan Central Hospital
OTHER
Xiangya Hospital of Central South University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xiangcheng Xiao
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xiangcheng Xiao, doctor
Role: PRINCIPAL_INVESTIGATOR
Xiangya Hospital of Central South University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Xiangya hospital
Changsha, Hunan, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
202108374
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.